These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28750150)

  • 21. Dermoscopic changes in malignant melanoma after successful treatment with nivolumab: A case report.
    Yamamura K; Otsuka A; Kaku Y; Seidel JA; Nomura M; Nagai H; Matsumoto S; Kabashima K
    J Dermatol; 2017 May; 44(5):547-548. PubMed ID: 27461159
    [No Abstract]   [Full Text] [Related]  

  • 22. The best treatments to use after checkpoint inhibition in melanoma.
    McArthur G
    Clin Adv Hematol Oncol; 2017 Apr; 15(4):242-245. PubMed ID: 28591097
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant nivolumab shows promise in MCC.
    Killock D
    Nat Rev Clin Oncol; 2023 Nov; 20(11):734. PubMed ID: 37507497
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination therapy of ipilimumab and nivolumab induced thyroid storm in a patient with Hashimoto's disease and diabetes mellitus: a case report.
    Yonezaki K; Kobayashi T; Imachi H; Yoshimoto T; Kikuchi F; Fukunaga K; Sato S; Ibata T; Yamaji N; Lyu J; Dong T; Murao K
    J Med Case Rep; 2018 Jun; 12(1):171. PubMed ID: 29914537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The use of ipilimumab in patients with rheumatoid arthritis and metastatic melanoma.
    Lee B; Wong A; Kee D; Neeson P; Shackleton M; McArthur G; Sandhu S
    Ann Oncol; 2016 Jun; 27(6):1174-1177. PubMed ID: 26861600
    [No Abstract]   [Full Text] [Related]  

  • 26. Metastatic Choroidal Melanoma Treated with Ipilimimab.
    Bogaard J; Czaja R; Wirostko WJ
    Ophthalmology; 2020 May; 127(5):600. PubMed ID: 32327132
    [No Abstract]   [Full Text] [Related]  

  • 27. Intra-arterial infusion therapy with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC 45388) for malignant melanoma.
    Einhorn LH; McBride CM; Luce JK; Caoili E; Gottlieb JA
    Cancer; 1973 Oct; 32(4):749-55. PubMed ID: 4751911
    [No Abstract]   [Full Text] [Related]  

  • 28. Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials.
    D'Angelo SP; Mahoney MR; Van Tine BA; Atkins J; Milhem MM; Jahagirdar BN; Antonescu CR; Horvath E; Tap WD; Schwartz GK; Streicher H
    Lancet Oncol; 2018 Mar; 19(3):416-426. PubMed ID: 29370992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nivolumab (OPDIVOO) BRAF V600 mutation-negative metastatic or inoperable melanoma: survival advantage.
    Prescrire Int; 2016 Dec; 25(177):289-292. PubMed ID: 30758924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Option Value of Innovative Treatments for Metastatic Melanoma.
    Thornton Snider J; Seabury S; Tebeka MG; Wu Y; Batt K
    Forum Health Econ Policy; 2018 Jun; 21(1):. PubMed ID: 30210050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting marker for early progression in unresectable melanoma treated with nivolumab.
    Kondo T; Nomura M; Otsuka A; Nonomura Y; Kaku Y; Matsumoto S; Muto M
    Int J Clin Oncol; 2019 Mar; 24(3):323-327. PubMed ID: 30168088
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune checkpoint blockade in oncodermatology: An ongoing revolution].
    Dereure O
    Ann Dermatol Venereol; 2018 Nov; 145(11):645-648. PubMed ID: 30224080
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunotherapy combined with high- and low-dose radiation to all sites leads to complete clearance of disease in a patient with metastatic vaginal melanoma.
    Sezen D; Patel RR; Tang C; Onstad M; Nagarajan P; Patel SP; Welsh JW; Lin LL
    Gynecol Oncol; 2021 Jun; 161(3):645-652. PubMed ID: 33795130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical Outcomes of Metastatic Melanoma Treated With Checkpoint Inhibitors and Multisite Radiotherapy.
    Doyen J; Picard A; Naghavi AO; Thyss A; Passeron T; Lacour JP; Montaudié H
    JAMA Dermatol; 2017 Oct; 153(10):1056-1059. PubMed ID: 28746710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel therapies for unresectable and metastatic melanoma.
    Karimkhani C; Reddy BY; Dellavalle RP; Sundararajan S
    BMJ; 2017 Nov; 359():j5174. PubMed ID: 29191943
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of nivolumab monotherapy against acral lentiginous melanoma and mucosal melanoma in Asian patients.
    Maeda T; Yoshino K; Nagai K; Oaku S; Kato M; Hiura A; Hata H
    Br J Dermatol; 2019 May; 180(5):1230-1231. PubMed ID: 30447078
    [No Abstract]   [Full Text] [Related]  

  • 37. Acute generalized exanthematous pustulosis associated with ipilimumab and nivolumab.
    Page B; Borradori L; Beltraminelli H; Yawalkar N; Hunger RE
    J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):e256-e257. PubMed ID: 28430376
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison of Solid Tumor Treatment Response Observed in Clinical Practice With Response Reported in Clinical Trials.
    Feinberg BA; Zettler ME; Klink AJ; Lee CH; Gajra A; Kish JK
    JAMA Netw Open; 2021 Feb; 4(2):e2036741. PubMed ID: 33630085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma Patients.
    Ishida Y; Otsuka A; Tanaka H; Levesque MP; Dummer R; Kabashima K
    J Invest Dermatol; 2017 Nov; 137(11):2443-2444. PubMed ID: 28736235
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary malignant melanoma of the uterine cervix or vagina which were successfully treated with nivolumab.
    Anko M; Nakamura M; Kobayashi Y; Tsuji K; Nakada S; Nakamura Y; Funakoshi T; Banno K; Aoki D
    J Obstet Gynaecol Res; 2020 Jan; 46(1):190-195. PubMed ID: 31608533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.